PerkinElmer, Inc. Expands Industry’s Largest Biochemical Protein Kinase Assay Portfolio to 310 Assays

CHICAGO--(BUSINESS WIRE)--PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, announced that it has expanded the industry’s largest reagent product portfolio for the detection and analysis of protein kinase activity to 310 assays.

MORE ON THIS TOPIC